Revance Therapeutics | 市值

Market Capitalization 更改 日
ALKERMES USD 4.63B 36M 2023-12
Neurocrine Biosciences USD 14.28B 1.33B 2024-03
Pacira USD 1.33B 234M 2024-03
Supernus Pharmaceuticals USD 1.89B 307M 2024-03



Revance Therapeutics 市值 - 当前值，历史数据，预测，统计，图表和经济日历 - Apr 2024.